Xenetic Biosciences (XBIO) Cash & Equivalents (2011 - 2026)
Xenetic Biosciences' Cash & Equivalents was $6.47 million in Q2 2026, up 35.4% from $4.78 million a year earlier but down 11.9% from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Xenetic Biosciences came in at $7.88 million, up 27.9% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -7.3% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $6.17 million in FY2024 (-31.4%), $8.98 million in FY2023 (-31.4%), $13.1 million in FY2022 (-28.2%) and $18.24 million in FY2021 (+58.3%).
- Quarterly Cash & Equivalents has moved between $4.12 million (Q3 2025) and $19.7 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for three straight quarters, with an average decline of 8.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 179.3%); the worst was Q3 2025 (a decline of 39.7%).
- Per Business Quant data, XBIO's Cash & Equivalents in the three quarters before Q2 2026 was $7.35 million (Q1 2026), $7.88 million (Q4 2025) and $4.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Xenetic Biosciences | 5.25 Mn | -20.58 Mn | - | 6.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 Mn |
| Mar 31, 2026 | 7.35 Mn |
| Dec 31, 2025 | 7.88 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 5.16 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 7.82 Mn |
| Dec 31, 2023 | 8.98 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 10.73 Mn |
| Mar 31, 2023 | 11.99 Mn |
| Dec 31, 2022 | 13.10 Mn |
| Sep 30, 2022 | 13.85 Mn |
| Jun 30, 2022 | 14.93 Mn |
| Mar 31, 2022 | 16.16 Mn |
| Dec 31, 2021 | 18.24 Mn |
| Sep 30, 2021 | 19.70 Mn |
API Access
Xenetic Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();